EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Cancer
This page brings together the European Medicines Agency's (EMA) latest information on cancer.
It lists the following:
12 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
Ojemda addresses unmet need for patients aged 6 months and older with paediatric brain tumour with BRAF alterations
Zynyz provides an option for adults with squamous cell carcinoma of the anal canal
Two new medicines recommended for approval; another eight medicines recommended for extension of their therapeutic indications
Currently, we have no events for this therapeutic area.